Outlook Therapeutics Inc (OTLK)
8.74
-0.18
(-2.02%)
USD |
NASDAQ |
May 01, 10:49
Outlook Therapeutics Price: 8.74 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 9.10 | 9.290 | 8.811 | 8.92 | 207150.0 |
Apr 29, 2024 | 8.35 | 9.19 | 8.35 | 9.10 | 177405.0 |
Apr 26, 2024 | 8.22 | 8.50 | 8.135 | 8.43 | 120913.0 |
Apr 25, 2024 | 8.14 | 8.37 | 7.85 | 8.19 | 150771.0 |
Apr 24, 2024 | 8.29 | 8.66 | 8.00 | 8.20 | 339980.0 |
Apr 23, 2024 | 8.21 | 8.44 | 8.15 | 8.20 | 151657.0 |
Apr 22, 2024 | 8.27 | 8.365 | 7.80 | 8.09 | 210765.0 |
Apr 19, 2024 | 8.28 | 8.63 | 8.00 | 8.17 | 271784.0 |
Apr 18, 2024 | 8.79 | 8.835 | 8.121 | 8.29 | 234621.0 |
Apr 17, 2024 | 8.93 | 9.26 | 8.53 | 8.61 | 418152.0 |
Apr 16, 2024 | 8.54 | 9.040 | 8.54 | 8.75 | 136801.0 |
Apr 15, 2024 | 8.50 | 8.79 | 8.44 | 8.62 | 234921.0 |
Apr 12, 2024 | 9.03 | 9.19 | 8.610 | 8.70 | 267111.0 |
Apr 11, 2024 | 9.09 | 9.34 | 8.75 | 9.04 | 394021.0 |
Apr 10, 2024 | 9.06 | 9.15 | 8.55 | 8.99 | 503035.0 |
Apr 09, 2024 | 9.35 | 9.98 | 9.03 | 9.26 | 359778.0 |
Apr 08, 2024 | 9.23 | 9.48 | 8.89 | 9.35 | 248028.0 |
Apr 05, 2024 | 9.50 | 9.61 | 9.050 | 9.26 | 198467.0 |
Apr 04, 2024 | 9.20 | 9.86 | 8.74 | 9.52 | 895790.0 |
Apr 03, 2024 | 9.78 | 10.21 | 9.00 | 9.12 | 774705.0 |
Apr 02, 2024 | 10.33 | 10.95 | 8.85 | 9.70 | 1.016M |
Apr 01, 2024 | 12.36 | 12.85 | 9.95 | 10.26 | 1.185M |
Mar 28, 2024 | 9.39 | 12.70 | 9.36 | 11.94 | 1.556M |
Mar 27, 2024 | 9.36 | 10.55 | 8.77 | 9.37 | 1.469M |
Mar 26, 2024 | 8.14 | 8.97 | 8.120 | 8.68 | 413743.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.072
Minimum
Sep 08 2023
66.20
Maximum
Feb 08 2021
26.53
Average
24.60
Median
Dec 05 2019
Price Benchmarks
Cutera Inc | 2.28 |
Actinium Pharmaceuticals Inc | 7.795 |
GT Biopharma Inc | 3.25 |
Karyopharm Therapeutics Inc | 1.11 |
Marinus Pharmaceuticals Inc | 1.44 |
Price Related Metrics
PS Ratio | 13.87 |
Earnings Yield | -45.77% |
Market Cap | 188.65M |